ZLAB INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Zai Lab LimitedPRNewsWire • 06/22/23
ZAI LAB ALERT: Bragar Eagel & Squire, P.C. is Investigating Zai Lab Limited on Behalf of Zai Lab Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 06/22/23
INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zai Lab Limited and Encourages Investors with Losses to Contact the FirmAccesswire • 06/21/23
INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Zai Lab Limited of an Investigation and Potential Class Action Lawsuit - (NASDAQ: ZLAB)PRNewsWire • 06/21/23
ZLAB NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Zai Lab LimitedPRNewsWire • 06/20/23
ROSEN, A LEADING LAW FIRM, Encourages Zai Lab Limited Investors with Losses to Inquire About Securities Class Action Investigation - ZLABPRNewsWire • 06/17/23
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Zai Lab Limited and Encourages Investors with Losses In Excess of $100,000 to Contact the FirmAccesswire • 06/15/23
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Zai Lab Limited and Encourages Investors with Losses to Contact the FirmAccesswire • 06/14/23
ZLAB INVESTOR NOTICE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Zai Lab Limited Investors with Losses to Inquire About Securities Class Action Investigation - ZLABPRNewsWire • 06/13/23
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zai Lab Limited and Encourages Investors with Losses to Contact the FirmAccesswire • 06/09/23
EQUITY ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Zai Lab Limited Investors with Losses to Inquire About Securities Class Action Investigation – ZLABBusiness Wire • 06/08/23
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Zai Lab Limited and Encourages Investors with Losses to Contact the FirmBusiness Wire • 06/07/23
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based TherapiesGlobeNewsWire • 06/06/23
Zai Lab to Highlight New Data from its Oncology Pipeline at 2023 ASCO Annual MeetingGlobeNewsWire • 06/01/23
Zai Lab Announces Strategic Partnership and Global License Agreement with MediLink Therapeutics for a Next Generation Antibody-Drug Conjugate Program in OncologyGlobeNewsWire • 04/27/23
Zai Lab Announces Presentation of Results of the LUNAR Phase 3 Clinical Trial in Non-Small Cell Lung Cancer at 2023 American Society of Clinical Oncology (ASCO) Annual MeetingGlobeNewsWire • 04/26/23
Zai Lab to Announce First Quarter 2023 Financial Results and Corporate Updates on May 9, 2023GlobeNewsWire • 04/20/23
Zai Lab to Highlight New Data from its Oncology Portfolio at 2023 AACR Annual MeetingGlobeNewsWire • 04/11/23